Comparison of effectiveness of adriamycin and epirubicin administered in the CHOP protocol to patients with malignant non-hodgkin's lymphoma
Rolski, J.; Koralewski, P.; Pawlicki, M.
Wiadomosci Lekarskie 46(9-10): 356-359
1993
ISSN/ISBN: 0043-5147 PMID: 8236992 Document Number: 417644
In a group of 30 patients with the diagnosis of malignant non-Hodgkin lymphoma of high histological malignancy, a prospective randomized study was carried out concerning the effectiveness and toxicity of the CHOP chemotherapy using adriamycin vs epirubicin. The effectiveness and tolerance of both treatment programmes are comparable. Good tolerance of the used epirubicin dose encourages to its increase in combined chemotherapy programmes in order to achieve higher therapeutic effectiveness.
Document emailed within 1 workday
Related Documents
Izumi, T.; Muroi, K.; Hoshino, Y.; Komatsu, N.; Ohtsuki, T.; Yamada, M.; Tomizuka, H.; Hatake, K.; Furusawa, S.; Miura, Y. 1996: Biweekly cyclophosphamide, epirubicin, vincristine and prednisolone (CEOP) chemotherapy for the elderly patients with aggressive non-Hodgkin's lymphoma. Tochigi Malignant Lymphoma Study Group for the Elderly Patients Gan to Kagaku Ryoho. Cancer and ChemoTherapy 23(6): 797-800Chuang, M.W.; Tzeng, C.H.; Chiou, T.J.; Chiu, C.F.; Hsieh, R.K.; Liu, J.H.; Chen, P.M. 1988: A comparative trial of C-novantrone OP(CNOP) vs C-adriamycin OP(CHOP) in the treatment of stage II-IV malignant lymphoma--the preliminary report Zhonghua Yi Xue Za Zhi 41(1): 51-56
Taguchi, H.; Shishido, T.; Niitsu, N.; Hiraoka, A.; Kageyama, T.; Kanamaru, A.; Ogawa, M. 1998: High-dose biweekly CHOP chemotherapy with granulocyte colony-stimulating factor support for patients with aggressive non-Hodgkin lymphoma Gan to Kagaku Ryoho. Cancer and ChemoTherapy 25(4): 523-529
Giménez-Mesa, E.; Martínez-Salio, A.; Porta-Etessam, J.; Berbel García, A.; Cedena Romero, T.; Salama Bendoyan, P. 2001: Reversible posterior leukoencephalopathy in a patient with non-Hodgkin's lymphoma after treatment with CHOP Anales de Medicina Interna 18(11): 591-593
István, L.; Balázs, L.; Brittig, F.; Pócza, K.; Szentcsiki, M.; Brenner, F. 1985: Incidence of highly malignant immunoblastic non-Hodgkin lymphoma in patients with Hodgkin's disease in remission Orvosi Hetilap 126(21): 1267-1272
Gaudin, P.; Rozand, Y.; Fauconnier, J.; Phelip, X. 1995: Rheumatic manifestations at presentation of Hodgkin's disease and non-Hodgkin's malignant lymphoma. A national survey of one hundred forty-six patients Revue du Rhumatisme 62(5): 365-375
Numbenjapon, T.; Sriswasdi, C.; Mongkonsritragoon, W.; Leelasiri, A.; Prayoonwiwat, W. 2002: Comparative study of low-dose oral granisetron plus dexamethasone and high-dose metoclopramide plus dexamethasone in prevention of nausea and vomiting induced by CHOP-therapy in young patients with non-Hodgkin's lymphoma Journal of the Medical Association of Thailand 85(11): 1156-1163
Rassweiler, J.; Rüther, U.; Bäuerle, K.; Bub, P.; Jipp, P.; Eisenberger, F. 1989: Polychemotherapy using the M-VEC protocol (methotrexate, vinblastine, epirubicin, cisplatin) in advanced urinary bladder cancer--effectiveness and toxicity Der Urologe. Ausg. a 28(1): 25-30
González Brito, G.; Marsá Vilá, L.; Chávez, M.I.; Batista López, N.; Hernández Nieto, L. 1985: Treatment of non-Hodgkin's lymphomas with CHOP-bleo. Experience in 16 patients Sangre 30(3): 367-368
Angrilli, F.; Pennese, E.; Di Marzio, A.; Liberatore, E.; Di Lorenzo, R.; Fioritoni, G. 2002: A dexamethasone, vinblastine, cyclophosphamide, etoposide, methotrexate and bleomycin (D-VICEMB) protocol as first-line treatment of patients aged 70 years or older affected by intermediate/high grade non-Hodgkin's lymphoma Haematologica 87(11): 1227-1229
Abele, R.; Alberto, P.; Germano, G.; Obrecht, J.P.; Wagenknecht, L. 1976: Simultaneous combination of adriamycin, bleomycin, cyclohexyl-chloroethyl nitrosourea with dimethyl-triazeno imidazole carboxamide in the treatment of Hodgkin's lymphoma Schweizerische Medizinische Wochenschrift 106(28): 961-963
Faradzhev, Z.G.; Samsonov, V.A.; Bassalyk, L.S.; Nemtsova, M.P. 1989: The effectiveness of treating patients with malignant skin lymphoma and Kaposi's sarcoma studied via polyamines Vestnik Dermatologii i Venerologii 11: 20-25
Visani, G.; Dinota, A.; Verlicchi, F.; Bandini, G.; Ricci, P.; Motta, M.R.; Rizzi, S.; Lemoli, R.M.; Poluzzi, C.; Gherlinzoni, F. 1988: Autologous bone marrow transplantation in patients with non-Hodgkin's lymphoma: comparison of different parameters in predicting the kinetics of haematological recovery Bone Marrow Transplantation 3(6): 599-605
Miller, T.P.; Jones, S.E.; Rainey, J.M. 1983: Cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) in patients with advanced Hodgkin's disease: a Southwest Oncology Group Phase Ii Study Cancer Treatment Reports 67(7-8): 739-740
Jandl, H.; Fuchs, R. 1979: Therapy of malignant non-Hodgkin's lymphoma Zeitschrift für die Gesamte Innere Medizin und ihre Grenzgebiete 34(7): 208-212
Deredzhian, A.; Etŭrska, M.; Boiadzhiev, T.; Todorov, D. 1982: Primary malignant non-Hodgkin lymphoma of the spleen Khirurgiia 35(6): 591-595
Chaouachi, B.; Trabelsi, M.; Dhaoui, R.; Ben Salah, S.; Ben Ayed, F.; Dellagi, K.; Bennaceur; Gharbi, H.A.; Saïed, H. 1989: Malignant non-Hodgkin's lymphoma of the abdomen in children La Tunisie Medicale 67(4): 271-277
Nakashima, M.; Ueno, Y.; Fujino, S.; Mori, A.; Okada, Y. 1982: Case of non-Hodgkin malignant lymphoma of the lung Nihon Kyobu Geka Gakkai 30(12): 2014-2018
Makarewicz, R.; Swirska, M.; Terlikiewicz, J. 1993: Non-hodgkin's malignant lymphoma in the uterine cervix Wiadomosci Lekarskie 46(23-24): 936-937
Stolzenbach, G.; Garbrecht, M.; Müllerleile, U. 1978: Intermittent chlorambucil-prednisone therapy in low malignancy non-Hodgkin lymphoma and cyclic induction chemotherapy with COP-bleomycin of severe non-Hodgkin lymphoma according to the Kiel classification Verhandlungen der Deutschen Gesellschaft für Innere Medizin 84: 177-180